TABLE 5.
Effect | Univariate logistic regression | Stepwise logistic regression | ||
---|---|---|---|---|
Odds ratio | p value | Odds ratio (95% CI) | p value | |
(95% CI) | ||||
Age >65 vs. < 65 | 0.06 (0.01–0.47) | 0.008 | 0.06 (0.00–0.88) | 0.04* |
Gender F vs. M | 0.82 (0.23–2.89) | 0.76 | 0.56 (0.07–4.52) | 0.59 |
Time from transplant to 3rd vaccine, years | 1.08 (0.95–1.23) | 0.22 | 1.16 (0.96–1.4) | 0.13 |
Time from 2nd to 3rd vaccine, days | 0.98 (0.93–1.03) | 0.43 | 1.01 (0.97–1.06) | 0.55 |
Time from 3rd vaccine to antibody testing, days | 0.94 (0.85–1.04) | 0.22 | 1.02 (0.87–1.20) | 0.81 |
ESRD secondary to DN yes/no | 0.26 (0.08–0.88) | 0.03 | 0.11 (0.02–0.74) | 0.02* |
eGFR (for every increase in 1 ml/min) | 1.04 (1.01–1.08) | 0.01 | 1.05 (1.00–1.09) | 0.04* |
Glucose per 1 mg/dl increase | 0.99 (0.98–1.00) | 0.14 | …............... | …............... |
Globulins per 1 mg/dl increase | 5.56 (0.99–31.2) | 0.05 | 7.56 (0.77–74.5) | 0.08 |
MPA use yes/no | 0.22 (0.03–1.78) | 0.16 | 0.09 (0.01–1.12) | 0.06 |
AbbreviationsDN, diabetic nephropathy; eGFR, estimated glomerular filtration rate; ESRD, end stage renal disease, MPA, mycophenolic acid.
<0.05.
When p value is significant, below 0.05 or below 0.01 the values are bolded.